Cargando…

Editorial: Translational imaging in neurodegenerative proteinopathies

Detalles Bibliográficos
Autores principales:	Ni, Ruiqing, Sahara, Naruhiko, Ji, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310556/ https://www.ncbi.nlm.nih.gov/pubmed/35898408 http://dx.doi.org/10.3389/fnins.2022.952449

Ejemplares similares

Editorial: Mechanisms of Action in Neurodegenerative Proteinopathies
por: Miller, Sean J., et al.
Publicado: (2022)

Editorial: Prodromal stage of neurodegenerative proteinopathies: from bench to bedside
por: Xu, Bin, et al.
Publicado: (2023)

Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia
por: Ni, Ruiqing, et al.
Publicado: (2022)

Chronic traumatic encephalopathy and other neurodegenerative proteinopathies
por: Tartaglia, Maria Carmela, et al.
Publicado: (2014)

Control of mRNA Translation in ALS Proteinopathy
por: Cestra, Gianluca, et al.
Publicado: (2017)

Karyopherin abnormalities in neurodegenerative proteinopathies
por: Pasha, Terouz, et al.
Publicado: (2021)

Neurodegenerative proteinopathies associated with neuroinfections
por: Danics, Krisztina, et al.
Publicado: (2021)

Drosophila melanogaster as a model to study autophagy in neurodegenerative diseases induced by proteinopathies
por: Santarelli, Stefania, et al.
Publicado: (2023)

Topographic Markers Drive Proteinopathies to Selection of Target Brain Areas at Onset in Neurodegenerative Dementias
por: Abbate, Carlo
Publicado: (2018)

Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases
por: Kawamata, Hibiki, et al.
Publicado: (2017)

Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies
por: Linsenmeier, Luise, et al.
Publicado: (2021)

Editorial: Translatable Models and MRI Methods for Neurodegenerative Diseases
por: Gatto, Rodolfo G., et al.
Publicado: (2022)

Correction: Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases
por: Kawamata, Hibiki, et al.
Publicado: (2018)

Promiscuous Roles of Autophagy and Proteasome in Neurodegenerative Proteinopathies
por: Limanaqi, Fiona, et al.
Publicado: (2020)

Neurodegenerative diseases as proteinopathies-driven immune disorders
por: Ciccocioppo, Fausta, et al.
Publicado: (2019)

Neurodegenerative Proteinopathies in the Proteoform Spectrum—Tools and Challenges
por: Noor, Aneeqa, et al.
Publicado: (2021)

Propagation of TDP-43 proteinopathy in neurodegenerative disorders
por: Keszycki, Rachel, et al.
Publicado: (2021)

Photo-Oxygenation as a New Therapeutic Strategy for Neurodegenerative Proteinopathies by Enhancing the Clearance of Amyloid Proteins
por: Tomizawa, Ikumi, et al.
Publicado: (2022)

Distinct Pattern of Microgliosis in the Olfactory Bulb of Neurodegenerative Proteinopathies
por: Kohl, Zacharias, et al.
Publicado: (2017)

Organotypic brain slice cultures to model neurodegenerative proteinopathies
por: Croft, C. L., et al.
Publicado: (2019)

Immunotherapy Targeting Neurodegenerative Proteinopathies: α-Synucleinopathies and Tauopathies
por: Shin, Junghwan, et al.
Publicado: (2020)

Dysregulation of Translation in TDP-43 Proteinopathies: Deficits in the RNA Supply Chain and Local Protein Production
por: Bjork, Reed T., et al.
Publicado: (2022)

Altered Mitochondrial Protein Homeostasis and Proteinopathies
por: Jishi, Aya, et al.
Publicado: (2022)

Editorial: Translational Advances in Alzheimer's, Parkinson's, and Other Neurodegenerative Dementias
por: Jiang, Jiehui, et al.
Publicado: (2022)

From clinical phenotype to proteinopathy: molecular neuroimaging in neurodegenerative dementias
por: Studart-Neto, Adalberto, et al.
Publicado: (2022)

Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention
por: Briston, Thomas, et al.
Publicado: (2018)

Molecular mechanisms of proteinopathies across neurodegenerative disease: a review
por: Marsh, Alexander P.
Publicado: (2019)

Untangling the origin and function of granulovacuolar degeneration bodies in neurodegenerative proteinopathies
por: Wiersma, Vera I., et al.
Publicado: (2020)

TDP-43 proteinopathies: a new wave of neurodegenerative diseases
por: de Boer, Eva Maria Johanna, et al.
Publicado: (2021)

Characteristics of Tau Oligomers
por: Ren, Yan, et al.
Publicado: (2013)

“Tau Oligomers,” What We Know and What We Don’t Know
por: Sahara, Naruhiko, et al.
Publicado: (2014)

Limitations of human tau-expressing mouse models and novel approaches of mouse modeling for tauopathy
por: Sahara, Naruhiko, et al.
Publicado: (2023)

Moving from neurodegenerative dementias, to cognitive proteinopathies, replacing “where” by “what”…
por: Allegri, Ricardo Francisco
Publicado: (2020)

Editorial: Innovative Imaging Techniques in Preclinical Models of Neurodegenerative Diseases
por: Gatto, Rodolfo G., et al.
Publicado: (2021)

Oligomers Are Promising Targets for Drug Development in the Treatment of Proteinopathies
por: Galzitskaya, Oxana V.
Publicado: (2020)

Editorial: Axonopathy in Neurodegenerative Disease
por: Burgess, Robert W., et al.
Publicado: (2018)

Revisit the Cellular Transmission and Emerging Techniques in Understanding the Mechanisms of Proteinopathies
por: Jiang, Jinwen, et al.
Publicado: (2021)

Neuronal models of TDP-43 proteinopathy display reduced axonal translation, increased oxidative stress, and defective exocytosis
por: Pisciottani, Alessandra, et al.
Publicado: (2023)

Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
por: Vuic, Barbara, et al.
Publicado: (2022)

Editorial: The underlying relationship between sleep and neurodegenerative diseases
por: Piñol-Ripoll, Gerard, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fqq4qfhe8u3aeravdcfml8ggj0